T2 lesions and rate of progression of disability in multiple sclerosis

被引:25
|
作者
Mostert, J. P. [1 ,2 ]
Koch, M. W. [1 ]
Steen, C. [1 ]
Heersema, D. J. [1 ]
de Groot, J. C. [3 ]
De Keyser, J. [1 ,4 ]
机构
[1] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands
[3] Univ Groningen, Dept Radiol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[4] Free Univ Brussels, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
关键词
disease progression; MRI; multiple sclerosis; prognosis; AXONAL LOSS; INTERFERON BETA-1B; PREDICTIVE-VALUE; MRI; DISEASE; TRIAL; ONSET; PHASE; MS;
D O I
10.1111/j.1468-1331.2010.03093.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients, who were clinically followed. There were 90 patients with progressive MS (35 secondary progressive and 55 primary progressive), and 96 with relapsing remitting MS. The rate of progression of disability was measured by time to sustained progression of disability (defined as an increase in >= 1 point when the Expanded Disability Status Scale (EDSS) was 5.5 or less and an increase in EDSS of >= 0.5 point when the EDSS was 6.0 or higher), and by the Multiple Sclerosis Severity Score (MSSS). Results: During follow-up (median 15 years, IQR 12-17 years), 94% of the patients with progressive MS and 50% of the patients with relapsing remitting MS had progression of disability. Higher T2 lesion number and load were modestly associated with a higher rate of disease progression on the MSSS and a shorter time to progression of disability in relapsing remitting MS, but not in progressive MS. Conclusions: Our findings indicate that the amount of T2 lesions has a small predictive value for progression of disability in relapsing remitting MS, but has no influence on the rate of progression in progressive MS.
引用
收藏
页码:1471 / 1475
页数:5
相关论文
共 50 条
  • [41] T1 and T2 weighted lesions and cognition in multiple Sclerosis: A systematic review and meta-analysis
    Nabizadeh, Fardin
    Pirahesh, Kasra
    Azami, Mobin
    Moradkhani, Asra
    Sardaripour, Alireza
    Ramezannezhad, Elham
    JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 119 : 1 - 7
  • [42] Cortical Thinning and Disability Progression in Multiple Sclerosis
    Fisher, Elizabeth
    Nakamura, Kunio
    Lee, Jar-Chi
    Rudick, Richard A.
    NEUROLOGY, 2011, 76 (09) : A324 - A325
  • [43] Confirmed disability progression as a marker of permanent disability in multiple sclerosis
    Sharmin, S.
    Malpas, C.
    Lechner-Scott, J.
    Slee, M.
    McCombe, P.
    Vucic, S.
    Butler, E.
    Hodgkinson, S.
    Barnett, M.
    Skibina, O.
    van der Walt, A.
    Buzzard, K.
    Shaw, C.
    Kermode, A.
    Taylor, B.
    Shuey, N.
    Macdonell, R.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (4_SUPPL) : 8 - 8
  • [44] Multiple sclerosis and pregnancy: relationship with progression of disability
    Masera, Silvia
    Prosperini, Luca
    Petsas, Nikolaos
    Mattioda, Alessandra
    Vercellino, Marco
    Cavalla, Paolo
    Pozzilli, Carlo
    MULTIPLE SCLEROSIS, 2008, 14 : S192 - S192
  • [45] Impact of comorbidities on the disability progression in multiple sclerosis
    Maric, Gorica
    Pekmezovic, Tatjana
    Tamas, Olivera
    Veselinovic, Nikola
    Jovanovic, Aleksa
    Lalic, Katarina
    Mesaros, Sarlota
    Drulovic, Jelena
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 24 - 29
  • [46] Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis
    Stevenson, VL
    Parker, GJM
    Barker, GJ
    Birnie, K
    Tofts, PS
    Miller, DH
    Thompson, AJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 178 (02) : 81 - 87
  • [47] Drug Slows Disability Progression in Multiple Sclerosis
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (20): : 2069 - 2069
  • [48] MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation
    Bakshi, R
    Shaikh, ZA
    Janardhan, V
    NEUROREPORT, 2000, 11 (01) : 15 - 21
  • [49] Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis
    Pravata, Emanuele
    Valsasina, Paola
    Gobbi, Claudio
    Zecca, Chiara
    Riccitelli, Gianna C.
    Filippi, Massimo
    Rocca, Maria A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (11) : 1402 - 1409
  • [50] Metabolomics associated with relapse rate and disability progression in relapse remitting multiple sclerosis patients
    Kitsos, D.
    Sideri, E.
    Chondrogianni, M.
    Tsivgoulis, A.
    Zompola, C.
    Thomaidis, N.
    Voumvourakis, K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 938 - 938